User profiles for Jinping Lai
Jinping LaiPenn State University; Rutgers University; Xiamen University Verified email at rci.rutgers.edu Cited by 1400 |
[HTML][HTML] Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer
Emerging data suggest that signaling by heparin-binding growth factors is influenced by the
sulfation state of N-acetylglucosamine residues of heparan sulfate proteoglycans (HSPGs). …
sulfation state of N-acetylglucosamine residues of heparan sulfate proteoglycans (HSPGs). …
Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial
…, R Lomonaco, SK Subbarayan, J Lai… - Diabetes …, 2019 - Am Diabetes Assoc
OBJECTIVE While vitamin E has shown to improve nonalcoholic steatohepatitis (NASH) in
patients without diabetes, information on patients with type 2 diabetes mellitus (T2DM) is …
patients without diabetes, information on patients with type 2 diabetes mellitus (T2DM) is …
Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release
We describe the development of a versatile fluorescence resonance energy transfer (FRET)-based
real-time monitoring system, consisting of (a) coumarin-labeled-cysteine tethered …
real-time monitoring system, consisting of (a) coumarin-labeled-cysteine tethered …
Real-time monitoring of ATP-responsive drug release using mesoporous-silica-coated multicolor upconversion nanoparticles
Stimuli-responsive drug delivery vehicles have garnered immense interest in recent years
due to unparalleled progress made in material science and nanomedicine. However, the …
due to unparalleled progress made in material science and nanomedicine. However, the …
Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage
…, D Carpenter, J Freebersyser, D King, J Lai… - Clinical …, 2019 - Elsevier
Background & Aims Noninvasive methods are needed to determine disease stage in patients
with nonalcoholic fatty liver disease (NAFLD). We evaluated the diagnostic performance of …
with nonalcoholic fatty liver disease (NAFLD). We evaluated the diagnostic performance of …
Familial adenomatous polyposis syndrome: an update and review of extraintestinal manifestations
…, NR Evans, NJ Phillips, J Lai… - … of pathology & …, 2019 - meridian.allenpress.com
Context.— Familial adenomatous polyposis (FAP) is a rare genetic disorder with autosomal
dominant inheritance, defined by numerous adenomatous polyps, which inevitably progress …
dominant inheritance, defined by numerous adenomatous polyps, which inevitably progress …
An upconversion nanoparticle with orthogonal emissions using dual NIR excitations for controlled two‐way photoswitching
Developing multicolor upconversion nanoparticles (UCNPs) with the capability of regulating
their emission wavelengths in the UV to visible range in response to external stimuli can …
their emission wavelengths in the UV to visible range in response to external stimuli can …
[PDF][PDF] Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
It has been shown that the heparin‐degrading endosulfatase, sulfatase 1 (SULF1), functions
as a liver tumor suppressor, but the role of the related sulfatase, sulfatase 2 (SULF2), in liver …
as a liver tumor suppressor, but the role of the related sulfatase, sulfatase 2 (SULF2), in liver …
Performance of plasma biomarkers and diagnostic panels for nonalcoholic steatohepatitis and advanced fibrosis in patients with type 2 diabetes
…, C Soldevilla-Pico, RJ Firpi-Morell, J Lai… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE The 2019 Standards of Medical Care in Diabetes suggested that patients with
nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. However, the …
nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. However, the …
Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L
The possible therapeutic benefits of B-cell depletion in combating tumoral immune escape
have been debated. In support of this concept, metastasis of highly aggressive 4T1 breast …
have been debated. In support of this concept, metastasis of highly aggressive 4T1 breast …